We are live on ! Find out more
ZCI

Zevenbergen Capital Investments Portfolio holdings

AUM $4.38B
1-Year Est. Return 56.68%
This Fund
S&P 500
This Quarter Est. Return
+17.79%
1 Year Est. Return
+56.68%
3 Year Est. Return
+239.32%
5 Year Est. Return
+232.55%
10 Year Est. Return
+3,491.87%
AUM
$3.15B
AUM Growth
+$145M
Cap. Flow
-$45.7M
Cap. Flow %
-1.45%
Top 10 Hldgs %
47.79%
Holding
88
New
2
Increased
34
Reduced
45
Closed
5

Top Buys

Rank Stock Value
1
TTD icon
Trade Desk
TTD
+$36.3M
2
TWOU
2U Inc
TWOU
+$22.3M
3
TLRY icon
Tilray
TLRY
+$21.3M
4
OKTA icon
Okta
OKTA
+$11.9M
5
EXAS
Exact Sciences
EXAS
+$11.9M

Sector Composition

Rank Sector Weight
1 Technology 27.95%
2 Consumer Discretionary 23.49%
3 Communication Services 18.54%
4 Healthcare 13.88%
5 Industrials 6.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOGL icon
26
Alphabet (Google) Class A
GOOGL
$4.2T
$45.3M 1.44%
749,920
+36,000
+5% +$2.18M
MDSO
27
DELISTED
Medidata Solutions, Inc.
MDSO
$45M 1.43%
614,286
+47,057
+8% +$3.76M
PCTY icon
28
Paylocity
PCTY
$7.73B
$43.1M 1.37%
536,730
-61,835
-10% -$4.38M
TTWO icon
29
Take-Two Interactive
TTWO
$45.4B
$41.7M 1.32%
302,380
+73,870
+32% +$9.43M
SHAK icon
30
Shake Shack
SHAK
$2.94B
$40.3M 1.28%
639,170
-30,680
-5% -$1.86M
SPOT icon
31
Spotify
SPOT
$101B
$40.2M 1.28%
222,380
-3,600
-2% -$660K
XYZ
32
Block Inc
XYZ
$47B
$39.9M 1.26%
402,549
+92,900
+30% +$7.17M
NVRO
33
DELISTED
NEVRO CORP.
NVRO
$38.4M 1.22%
673,480
+5,750
+0.9% +$359K
BMRN icon
34
BioMarin Pharmaceuticals
BMRN
$13.6B
$37.6M 1.19%
387,875
-10,100
-3% -$1.01M
CSGP icon
35
CoStar Group
CSGP
$12.4B
$36.2M 1.15%
860,370
-24,850
-3% -$1.06M
PTLA
36
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$30.3M 0.96%
1,137,055
-116,570
-9% -$3.81M
FRC
37
DELISTED
First Republic Bank
FRC
$26M 0.83%
270,963
-88,135
-25% -$8.87M
AXON
38
Axon Enterprise
AXON
$48.7B
$12.8M 0.41%
187,470
+22,540
+14% +$1.52M
AVLR
39
DELISTED
Avalara, Inc.
AVLR
$7.42M 0.24%
212,480
-1,085
-0.5% -$44.9K
V icon
40
Visa
V
$671B
$7.19M 0.23%
47,890
-12,701
-21% -$1.81M
PS
41
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$4.9M 0.16%
+153,135
New +$4.5M
AAPL icon
42
Apple
AAPL
$4.41T
$3.46M 0.11%
61,220
-10,736
-15% -$559K
SFIX
43
Stitch Fix
SFIX
$474M
$3.42M 0.11%
78,070
+10,850
+16% +$395K
MSFT icon
44
Microsoft
MSFT
$3.66T
$3.1M 0.1%
27,109
-359
-1% -$38.9K
JPM icon
45
JPMorgan Chase
JPM
$971B
$2.07M 0.07%
18,305
+5,577
+44% +$633K
BDX icon
46
Becton Dickinson
BDX
$50B
$2.05M 0.07%
8,062
-549
-6% -$135K
ZTS icon
47
Zoetis
ZTS
$30.4B
$1.93M 0.06%
21,045
-2,785
-12% -$247K
INTU icon
48
Intuit
INTU
$91.6B
$1.82M 0.06%
8,004
-3,325
-29% -$714K
BKNG icon
49
Booking.com
BKNG
$159B
$1.73M 0.05%
21,750
-9,100
-29% -$716K
LASR icon
50
nLIGHT
LASR
$3.06B
$1.73M 0.05%
77,725
-44,400
-36% -$1.39M

Similar funds

Zevenbergen Capital Investments's Q3 2018 Portfolio in Review

As of Q3 2018, Zevenbergen Capital Investments held 88 positions worth $3.15B, up 4.8% from $3.01B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Zevenbergen Capital Investments's Q3 2018 filing shows 2 new, 34 increased, 45 reduced and 5 closed positions. Its largest new stake was Tilray: 33,094 shares worth $47.5M. The largest sale was Celgene Corp, an estimated $39.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Zevenbergen Capital Investments's largest Q3 2018 buy was Tilray: 33,094 shares worth $47.5M.
  • Zevenbergen Capital Investments added most to Trade Desk in Q3 2018, an estimated $36.3M increase.
  • Zevenbergen Capital Investments's biggest Q3 2018 reduction was Amazon, cutting an estimated $28.4M.
  • Zevenbergen Capital Investments fully exited Celgene Corp in Q3 2018, selling an estimated $39.4M.
  • Zevenbergen Capital Investments's ten largest holdings make up 48% of its $3.15B portfolio in Q3 2018.
  • Zevenbergen Capital Investments opened 2 new positions and closed 5 in Q3 2018.
  • Zevenbergen Capital Investments's portfolio value rose 4.8% quarter-over-quarter to $3.15B.

Based on Zevenbergen Capital Investments's 13F filing for Q3 2018, filed 13 Nov 2018.